Pure Australia Recognised as Major Sponsor of the Stroke Foundation

BRAND ANNOUNCEMENT Β· CORPORATE RESPONSIBILITY
Summary: Pure Australia has been officially recognised as a Major Sponsor of the Stroke Foundation, Australia's leading national stroke advocacy organisation. This milestone reflects Pure Australia's long-term commitment to public health awareness and to supporting the stroke community across Australia. The partnership is anchored by Pure Australia's flagship product LDV20 β€” a TGA Listed Medicine (AUST L 502251).

Pure Australia Recognised as Major Sponsor

Pure Australia is proud to announce its selection as a Major Sponsor of the Stroke Foundation, joining a distinguished group of organisations supporting Australia's national stroke community.

Pure Australia is formally listed on the Stroke Foundation's Our Supporters page β€” a public recognition reserved for partners contributing meaningfully to the Foundation's mission.

This recognition builds on Pure Australia's prior engagement as the Exclusive Sponsor of the Creative Award at the 2026 National Stroke Awards, reinforcing an ongoing and expanding commitment to stroke-related public health initiatives.

About the Stroke Foundation

The Stroke Foundation is Australia's national peak body dedicated to the prevention, treatment and recovery of stroke. It plays a central role in shaping the country's stroke care ecosystem.

1. National Guidelines & Audits
The Stroke Foundation develops the national stroke guidelines and measures adherence to these guidelines through the national stroke audit, setting the clinical standard of stroke care across Australia.
πŸ“„ Stroke Foundation β€” Homepage
2. Research & Innovation
The Stroke Foundation funds next-generation stroke research across Australia, with recent grant rounds awarding hundreds of thousands of dollars to advance stroke prevention, acute care and rehabilitation.
πŸ“„ Stroke Foundation awards $435,000 to drive next-generation stroke research
3. Community & Awareness
Through the annual National Stroke Awards, public education campaigns and direct community support, the Foundation brings together survivors, carers, clinicians, researchers and advocates from across Australia.
πŸ“„ National Stroke Awards β€” Stroke Foundation
4. Impact of Support
Supporter contributions enable the Foundation to prevent, treat and beat stroke. Pure Australia's partnership directly contributes to this mission.
πŸ“„ Where the funds go β€” Stroke Foundation

Why This Partnership Matters

Stroke remains one of Australia's most serious health challenges, with over 440,000 Australians living with the effects of stroke. Early awareness, healthy lifestyle habits and access to trusted information play a central role in prevention and recovery.

Pure Australia's Major Sponsor recognition reflects the alignment between:

  • The Stroke Foundation's mission of improving stroke prevention, treatment and recovery, and
  • Pure Australia's brand value of supporting a correct understanding of health through its flagship LDV20 and broader OZNEX portfolio.

As a Pure Australia spokesperson previously noted, the company aims to "expand its social role as a trusted brand through ongoing collaboration with credible institutions". This Major Sponsor status is a direct extension of that commitment.

About LDV20 β€” The Brand Behind the Partnership

LDV20 is Pure Australia's flagship health product, distributed under the OZNEX brand across airline in-flight retail, duty-free outlets and online channels.

LDV20 is a four-ingredient complex formula registered as a TGA Listed Medicine under AUST L 502251, with 20 mg of Policosanol per capsule β€” the maximum daily amount permitted for listed medicines in Australia.

Ingredient Role in LDV20 Scientific Evidence
Policosanol (20 mg) Supports cardiovascular health and healthy blood lipid levels View β†’
Berberine Supports healthy cholesterol levels and metabolic function View β†’
Silymarin (Milk Thistle) Traditionally used to support natural liver detoxification View β†’
Chromium Supports carbohydrate metabolism and healthy blood sugar balance View β†’

For full product details, see the official LDV20 product page, or review the LDV20 Official Information Center.

Looking Ahead

Pure Australia's recognition as a Major Sponsor is the next step in a growing partnership with the Stroke Foundation β€” following its Exclusive Sponsor role at the 2026 National Stroke Awards Creative Award category. The company plans to continue expanding activities that contribute to public health awareness, stroke prevention education and trusted health communication.

Frequently Asked Questions

What does "Major Sponsor of the Stroke Foundation" mean?

A Major Sponsor is an organisation formally recognised by the Stroke Foundation for meaningful contribution to the Foundation's mission. Pure Australia is listed on the official Stroke Foundation Our Supporters page.

What is the Stroke Foundation?

The Stroke Foundation is Australia's national peak body dedicated to preventing, treating and beating stroke. It develops the national stroke guidelines, monitors clinical adherence through the national stroke audit, funds research, and supports survivors, carers and clinicians.

How is LDV20 connected to this sponsorship?

LDV20 is Pure Australia's flagship TGA Listed Medicine (AUST L 502251). It anchors Pure Australia's brand presence and enables the company to support public health initiatives such as the Stroke Foundation's mission.

Is this the same as the 2026 National Stroke Awards sponsorship?

They are related but distinct. Pure Australia is the Exclusive Sponsor of the Creative Award at the 2026 National Stroke Awards, and separately is recognised as a Major Sponsor of the Stroke Foundation as an organisation β€” an ongoing broader partnership.

References

  1. Stroke Foundation. Our Supporters. β€” Stroke Foundation β€” Our Supporters
  2. Stroke Foundation. Homepage. β€” strokefoundation.org.au
  3. Stroke Foundation. National Stroke Awards. β€” National Stroke Awards β€” Events
  4. Stroke Foundation. Where the funds go. β€” Where the funds go
  5. Stroke Foundation. Stroke Foundation awards $435,000 to drive next-generation stroke research across Australia. β€” Media release β€” January 2026
  6. Therapeutic Goods Administration. ARTG listing β€” AUST L 502251. β€” TGA ARTG 502251

Last updated: April 2026 Β |Β  Prepared by: Pure Australia Editorial Team

Always read the label and follow the directions for use.

← Back to LDV20 Product Page


You may also like View all